The HBA Gathers Top Industry Leaders for Groundbreaking ... · Chris McMorrow Senior Copywriter...

THE NEWSLETTER OF THE HEALTHCARE BUSINESSWOMEN’S ASSOCIATION Advancing Women’s Careers JULY/AUGUST 2003

turn to HBA CHAPTER UPDATE on page 4

A

3RD BIENNIAL WOMEN’S LEADERSHIP CONFERENCE

The HBA Gathers Top Industry Leaders forGroundbreaking Two-Day Conference

HBA Chapters Update

turn to LEADERSHIP CONFERENCE on page 4

Kim RoweManaging Partner, Agentive Sales and Marketing Solutions

ccording to Harold J. Seymour, “Whenthe leadership is right and the time is right,the people can always be counted upon to

follow—to the end and at all costs.” A record num-ber of women demonstrated that the time was rightfor leadership by attending the HBA’s 3rd BiennialWomen’s Leadership Conference June 5th-6th at theOcean Place Conference Resort in Long Branch,NJ. The conference, entitled “Responsibilities ofLeadership,” gave participants an opportunity todevelop a deep understanding of the many arenas inwhich leadership plays a role in addition to the cor-porate environment: the family, community, andoneself.

“After more than a quarter-century devoted toadvancing women’s careers in healthcare, the HBA has emergedas an Association that is unparalleled in its ability to providecutting-edge information presented by leading industry pro-fessionals. This fact has never been more apparent than at the

recent Leadership Conference, which broke all records for at-tendance,” noted HBA President, Nancy Larsen, PresidentPROmedica Communications, Inc. (New York, NY).

Britta HerlitzPresident, Herlitz HealthCare:A Communications Co.; Editor, HBA Bulletin

The Atlanta Chapter of the HBAOn June 26th, the HBA’s Atlanta Chap-

ter hosted a highly successful and informa-tive evening dinner seminar entitled “WhyYour Employees Don’t Do What You Ex-pect Them to Do.” The event featuredspeaker Linda Kobel of the Link SolutionsGroup (Marietta, GA).

On August 20th, the chapter will hostrenown author Gail Evans who will in-troduce her new book, She Wins, You Win:A Guidebook for Making Women More

Powerful. For additional information onthis program, please contact Juliann Kai-ser at phone: (770)643-0615; email:[email protected].

Look for more news on the chapter’supcoming October event in the next is-sue of the HBA Bulletin.

The Boston Chapter of the HBAThus far, 15 candidates have applied for

the six open positions on the chapter’s Boardof Directors, according to Deborah Furey,Director, Healthcare Solutions, Braun Con-sulting Services (Boston, MA) and MichelleMcCarthy, Executive Recruiter, CarterMcKay (Quincy, MA). Requirements in-

clude: strong leadership capabilities, com-mitment to the advancement of womenin healthcare, current employment in thehealthcare or service related industries andwillingness to assume additional respon-sibilities to make the HBA’s Boston Chap-ter a continued success and strong pres-ence in the community. For additionalinformation, contact Furey [email protected] or McCarthyat [email protected].

In program news, the BostonChapter’s June event, “Healthy, Wealthyand Wise, Planning for Your Strong andSuccessful Financial Future Working inthe Healthcare Industry,” was an enor-mous success. Featuring speaker PaulaChauncy, CFA and Founder, être LLC

(Left to right): Leadership Conference Co-chair and HBA Co-director of CareerDevelopment ANNE CAMILLE MAHER, Health Leaders; HBA President-Elect DARIA

BLACKWELL, White Seahorse, Inc.; CATHERINE ROBINSON-WALKER, author;MARGARET G. MCGLYNN, Merck & Co., Inc.; Past HBA Woman of the Year SARAH S.

HARRISON, AstraZeneca Pharmaceuticals LP; HBA President NANCY LARSEN,PROmedica Communications, Inc.; and Leadership Conference Co-chair and HBA

Director of Communications DONNA K. RAMER, HealthMed Public Relations.

www.hbanet.org

2 www.hbanet.org HBA Bulletin July/August 2003

FACILITATING GLOBALIZATION IN AN INTERNATIONAL COMPANY

Experts Share Strategies for Success inGlobal Marketing

MEETING HIGHLIGHTS

Chris McMorrowSenior CopywriterBruce Leeb & Company

HBA members turned out inforce for the April 3rd semi-nar on global marketing atNovartis PharmaceuticalsCorporation (East Hanover,NJ). Following the tradi-tional “Eat and Greet” pe-riod, the audience heard di-verse viewpoints from apanel of five experts, each ofwhom shared specific chal-lenges their companies facedin marketing pharmaceuti-cals outside the US.

Following welcoming remarks by pro-gram co-host Debra E. Freire, Vice Presi-dent, Diversity & Workforce Potential atNovartis, HBA President Nancy Larsen,President, PROmedica Communications,Inc. (New York, NY) introduced the panel,led by co-host and moderator Bette Schultz,VP, US Business Development and Licensingat Novartis. Challenging each panelist to ad-dress a key question—“How do you define thedifference between ‘global’ and ‘international’in the context of pharmaceutical market-ing?”—Schultz asked them to then outlineone or two key issues their companies viewedas critical for success in planning or execut-ing a global marketing program.

For Benito Cachinero,Worldwide VP, Human Re-sources, at Ethicon, Inc.(Somerville, NJ), “global” re-fers to structure and systems,or the “hardware” of pro-grams developed outside theUS, whereas “international”encompasses the culture, val-ues and “DNA” of companyemployees. According toCachinero, great companieslike Microsoft and HewlettPackard operate by adhering

to a common set of values that ensures theright people are in place to carry out corpo-rate principles, anywhere they work. AtEthicon, corporate values are not only highlyprized, universally shared, and prominentlydisplayed in the local language of offices all overthe world, they are lived and followed becauseof their ubiquity throughout the company.

Novartis Senior VP and North AmericanRegion Head Deborah Dunsire, MD, sees“global” as a cohesive term where the wholeis greater than the sum of each part. For Dr.Dunsire, “international” is more a series ofsegmented markets that can often unleashperverse incentives. In her view, leadershipis the key factor in driving global marketingsuccess. Crediting Novartis with empower-

The Panel: (left to right) BENITO CACHINERO, Ethicon, Inc.; DEBORAH

DUNSIRE, MD, Novartis Pharmaceuticals Corporation; KIMBERLY A.WHITE, Ogilvy Public Relations Worldwide; LISA SHAPIRO, StrategicSolutions Group; and BARBARA SCHMIDT-KEMP, Ernst & Young LLP.

DEBRA E. FREIRE, NovartisPharmaceutials Corporationgave the opening remarks.

BETTE SCHULTZ, NovartisPharmaceuticals Corporation

moderated the program.

is published bimonthly for the members of theHealthcare Businesswomen’s Association, 333BRoute 46 West, Suite B-201, Fairfield, NJ 07004.Phone: (973) 575-0606 Fax: (973) 575-1445E-Mail: [email protected] Web: www.hbanet.org

EDITORBritta Herlitz

CREATIVE CONTRIBUTORRosemary AzzaroMANAGING EDITOR

Joanne TanziCHAPTERS CORRESPONDENT

Kim RoweART DIRECTOR

DeborahAnne Chingas SandkeADMINISTRATIVE COORDINATOR

Rosanne GogertyPlease send correspondence regarding theHBA Bulletin to: Joanne Tanzi at the aboveaddress.

HBA BOARD OF DIRECTORSPRESIDENT—Nancy Larsen, President, PROmedica

Communications, Inc.PRESIDENT ELECT—Daria O. Blackwell, President,

White Seahorse, Inc.IMMEDIATE PAST PRESIDENT—Mary E. Cobb, CEO/

President, PACE, Inc., a Lowe Healthcare CompanyFIRST VICE PRESIDENT—Barbara M. Pritchard,

President, The Pritchard GroupSECOND VICE PRESIDENT—Patricia Pesanello,

Chief Knowledge Strategist for Pharmaceuticals &Health Sciences, BusinessEdge Solutions

SECRETARY—Lynne Allegra, Pfizer Inc.TREASURER—Kathleen Milligan, Vice President,

Marketing and Sales, Endeavor PharmaceuticalsCO-DIRECTORS OF CAREER DEVELOPMENT—

Anne Camille Maher, Consultant, Health LeadersandLisa Courtade

DIRECTOR OF COMMUNICATIONS—Donna Ramer, PR Consultant, HealthMedCommunications

CO-DIRECTORS OF MARKETING—Ilyssa Levins, Chairman and Chief ExecutiveOfficer, GCI Healthcare andDebra L. Newton, President and CEO, NewtonGravityShift

CO-DIRECTORS OF MEMBERSHIP—Janna K. Calhoun, Vice President, Taylor NelsonSofres Intersearch, Inc. andElizabeth M. Mutisya, MD, Senior Director/Clinical Leader, DNA, Analgesia, Johnson & Johnson

CO-DIRECTORS OF PROGRAMS—Stephanie G. Phillips, PhD, President, ProjectHouse, Inc. andJill Quist, Vice President, Client Services,Right Management Consultants

PAST PRESIDENT–STRATEGIC PLANNING—Teri P. Cox, Senior Managing Partner, CoxCommunications Partners

ATLANTA CHAPTER PRESIDENT— Jan Hannon,President, Envision Communications, Inc.

BOSTON CHAPTER PRESIDENT— Karla Gonye,Boston District Sales Manager, Schering Labs

SAN FRANCISCO BAY AREA CHAPTER PRESIDENT—Heather Simonsen, Commercialization Manager,Cholestech

ADMINISTRATORSEXECUTIVE DIRECTOR—Carol Davis-Grossman,The Charles Group, Inc.ASSOCIATE DIRECTOR — Susan Dunkelman,The Charles Group, Inc.

HBA COMMITTEESASSOCIATION RELATIONS—Patricia PesanelloCHAPTERS—Leigh Ann SoltysiakCORPORATE MEMBERSHIP—Sharon CallahanEXECUTIVE WOMEN’S BREAKFAST (AD HOC)—Shellie CaplanFINANCE—Kathleen M. MilliganINDIVIDUAL MEMBERSHIP— Harriet GruberLEADERSHIP CONFERENCE—Donna Ramer and Anne

Camille MaherNEWSLETTER—Britta HerlitzNOMINATING—Mary E. CobbPROMOTION—Lisa MelePUBLIC RELATIONS—Lisa MeleRESEARCH—Rose RiosSTRATEGIC PLANNING—Teri P. CoxVOLUNTEERS—Charlene ProunisWEB SITE—Debra NewtonWOMAN OF THE YEAR—Mary E. Cobb and Daria O. Blackwell

Meeting Photos by Joe Vericker/PHOTOBUREAU, Inc.

HBA Bulletin July/August 2003 www.hbanet.org 3

ing its leaders to set overall vision andstrategy, as well as goals and targets, Dr.Dunsire emphasized their reliance onteamwork, collaboration, and above allcommunication to help overseas mar-keters manage numerous ambiguitiesthat arise when the terrain is unfamil-iar or rapidly shifting.

On the vendor side, Kym White,Managing Director of the New YorkCity office of Ogilvy Public RelationsWorldwide, sees “global” used three dif-ferent ways: as “pan European” (in toomany instances); as “the top ten non-US pharma markets” (the majority ofcases); and finally as “all the countriesunderserved with resources, and thuswilling to seek guidance and listen” (alltoo often in reality).

Humor aside, White acknowledgedthat budgets and resources represent anenormous hurdle in planning global PRprograms. “Let’s face it, US budgets arelarger than all the rest of the world puttogether, which exacerbates the task ofplanning for differing launch dates,drug names, therapeutic indications,and distribution arms—the issues that

TIME TO MAKE A DIFFERENCE

The HBA is a volunteergroup, and its success isdue to countless hoursof time spent by mem-bers to plan and ex-ecute programs, pub-lications, and otherservices.

At the Aprilmeeting, HBA Presi-

dent Nancy Larsen, President, PROmedicaCommunications, Inc. (New York, NY), honoredJILL QUIST, Vice President, Business Develop-ment and Consulting Solutions, Northeast, RightManagement Consultants (Maplewood, NJ) asthe recipient of the HBA’s “Time to Make a Differ-ence” award. Quist has been the HBA’s Co-Di-rector of Programs, having worked long and hardfor several years. She is in charge of producing50% of all of the HBA’s evening seminars and hasworked tirelessly to present professional pro-grams aligning content with member needs. Inresponse to her efforts, the HBA has seen an over-whelming attendance at evening programs.

Program facilitators (left to right): ANITA BURRELL,Aventis Pharmaceuticals; JOY D. APPLEBAUM;

PATRICIA JAEGER, Ventiv Health U.S. Sales;LYNN BROWN, Wright Management Consultants; and

JULIE B. KAMPF, JBK Associates, Inc.

so often bedevil communi-cations agencies seeking tobuild global brands,” Whitedeclared. “To make the mostof less, we try to determinewhat’s truly needed in localmarkets in order to be as cre-ative as possible in settinggoals. Increasingly we mightconsider starting small, usingpilot programs to demon-strate results that will winmatching funds from otherareas of the global budget.But the most important

thing our team can do to help buildthe global brand is to establish solidcommunications norms from whichthe various countries can deviate.”

The final two panelists focused onstaffing structure and HR develop-ment, critical fac-tors for compa-nies with globalmarketing pro-grams. LisaShapiro, formerlywith Pfizer Inc.and now Princi-pal, Strategic So-lutions Group(New York, NY),stresses the valueof having a formalglobal team struc-ture with fully dedicated team mem-bers over a looser, more diffuse cross-functional team. Barbara Schmidt-Kemp, Partner in the Human CapitalPractice at Ernst & Young LLP (Iselin,NJ), thinks changes in staffing trendsover the past three decades are makingit easier for employees to pursue pro-

fessional growth abroad. Ac-cording to Schmidt-Kemp,companies have moved be-yond older hierarchical, pa-ternalistic ways of thinkingthat invested in human capi-tal via long-term overseas as-signments. Today, the opera-tive mode is shorter interna-tional assignments withgreater reliance on knowl-edge transfer, allowing em-ployees greater mobility, flex-

SPECIAL THANKS TONovartis Pharmaceuticals Corporation for sponsor-ing this event and for providing facilities for this pro-gram; to Co-Directors of Programs JILL QUIST,Vice President, Business Development & Consult-ing Solutions, Northeast, Right Management Con-sultants (Maplewood, NJ) and STEPHANIEPHILLIPS, PhD, President, Project House, Inc.(Hackensack, NJ); and to Program OrganizersJULIE KAMPF, President, JBK Associates, Inc.(Englewood, NJ) and MEGAN O’KEEFE, BusinessDevelopment Manager, Institute for InternationalReserch (New York, NY).

(Left to right): DENISE BRAEBEAR, KIM CALLAHAN, GINA

MORAN, LAURIE RYAN, AND CHRISTINE LANDY, all ofNovartis Pharmaceuticals Corporation.

(Left to right): ROBERT SHEKHDAR and KAREN TIBBALS, both ofIPSOS-NPD with SANDKPA DUBLISH, EMMIE IAN, and STACY VAUGHN,

all from Novartis Pharmaceuticals Corporation.

ibility, and the chance to quickly amassexperience across disciplines. �

Chris McMorrow has more than ten yearsof experience writing for healthcare, phar-maceutical marketing, and medical educa-tion companies, including 7 at ThomsonPhysicians World.


(Boston, MA), the overriding message ofthe event was: Invest now. Understandyour risk threshold; learn how much is“enough” to achieve your goals anddreams, and make the sacrifices necessaryto get there. Chauncy cited some unset-tling statistics: Women continue to makeonly 75 cents to every dollar earned bytheir male counterparts and seven out often women cannot afford to retire. Forthese reasons and many others, it is es-sential to have a plan and to implementit now, regardless of your income,Chauncy emphasized. “Don’t count onsalary, plus bonus, plus options to createyour wealth!”

The chapter’s next program will be onSeptember 23rd and will focus on productlaunch and commercialization in the biotecharena. This important event will be spon-sored by Biogen (Cambridge, MA).

Volunteers are needed for the chapter’sNewsletter Committee. If you’re inter-ested, contact Chapter President, Karla

Gonye, District Manager, Schering Labo-ratories (Plymouth, MA) [email protected].

The San Francisco/Bay Area(SFBA) Chapter of the HBA

The HBA’s SFBA Chapter hosted its2nd Annual Dinner on May 29th at theSan Mateo Marriott (San Mateo, CA).The topic under exploration “The Con-vergence of the Pharmaceutical, Biotech,and Medical Device Industries” was com-pelling and drew an impressive line-upof speakers. Ginger Graham, CEO-elect,Amylin Pharmaceuticals (San Diego, CA)was the keynote speaker. Graham wasfollowed by Julia Brown, also of Amylin,and Abbie Celniker of Millenium Phar-maceuticals (headquarters in Cambridge,MA). The event was [over]sold-to-capac-ity with an extensive waiting list—it couldscarcely have been more successful.

This year the HBA’s SFBA Chapterpremiered a new annual award—the “In-novator of the Year” Award which went

to Jennie Mather, CEO of Raven Bio-technologies, Inc.(South San Francisco,CA).

On June 17th, the chapter held an-other successful seminar, entitled “CareerBreakthroughs: Executive Perspectives.”The event was held at Chiron Corpora-tion (Emeryville, CA). As with the an-nual dinner, this event showcased an im-pressive array of top female executives,each of whom traveled a distinct careerpath to reach her current leading posi-tion in the life sciences industry—apply-ing lessons and skills developed in othersectors such as high tech and the provider-side of the healthcare industry.

A third successful spring/summerevent was held on July 16th when silver-level corporate sponsor of the HBA’sSFBA Chapter, Cooley Godward, LLP(Palo Alto, CA), hosted a FREE summerevening networking event at their beau-tiful outdoor patio location. Look formore news on this in the next issue of theHBA Bulletin. �

HBA CHAPTERS UPDATE from page 1

“The HBA recognized that leadership issues were particu-larly relevant given the current business climate, which has beenreinforced by the results of a recent survey conducted by theHBA in collaboration with Pharmaceutical Executive magazine,”said Daria Blackwell, HBA President-Elect and President,White Seahorse, Inc. (Mahwah, NJ), during an onsite inter-view with the HBA Bulletin. “Moreover, we understood thatproviding many of the tools needed to help develop and pre-serve integrity would be of significantvalue as conference attendees fulfill theirleadership roles at all levels.” (Note: Re-sults of the HBA survey on leadershiptraits and attributes will be reported infull in a special Pharmaceutical Executivesupplement in August and summarizedin the next issue of the HBA Bulletin).

Larsen kicked-off the full-day confer-ence (which followed a day of relaxingspa treatments and networking) by welcoming everyone. Sheset the tone of the day through a video montage of industryleaders who helped define the traits and attributes of leaders aswell as the HBA’s role to provide many resources to help womenin the industry improve their own leadership skills.

Morning Keynote Addresses Integrity in LeadershipRenowned author Catherine Robinson-Walker was both

compelling and timely as she addressed Integrity in Leadership.Robinson-Walker, who is Executive Director of the Academy

for Healthcare Quality; President, The Leadership Studio (Oak-land, CA), and author, Women and Leadership in Health Care:The Journey to Authenticity and Power defines integrity as, “Whoyou are, and what you stand for. It’s honesty and morality, andit’s dynamic, not static. Integrity is developed, practiced andrenewed constantly, not simply born. There are daily practicesthat we can adopt to enhance our integrity.” She added thatour own internal monitors tell us when we are acting with in-tegrity because we feel clear, self-confident, powerful and au-

thentic; we feel the course of action we are taking isright for us. Conversely, when we take actions thatare outside our own integrity, we feel fearful, un-comfortable, and out of balance.

Merck’s Margie McGlynn ProvidesPersonal, Professional Insights duringKeynote Address

One of the industry’s most senior women, Mar-garet G. McGlynn, President, US Human Health

Care, Merck & Co., Inc. (West Point, PA), began her keynoteaddress by quoting her 9-year-old daughter, who said: “Lead-ers aren’t afraid to do what’s right. They are responsible. Youcan trust a leader.”

McGlynn then focused on two primary goals to make adifference in the current healthcare system: restoring and en-hancing trust and integrity, and improving access to healthcareproducts, including pharmaceuticals, in the U.S. She contendsthat trust in our nation’s leaders — in all walks of life, includ-

LEADERSHIP CONFERENCE from page 1

turn to LEADERSHIP CONFERENCE on page 5

“Integrity is developed,practiced and

renewed constantly,not simply born.”

—CATHERINE ROBINSON-WALKER

HBA BULLETIN JULY/AUGUST 2003 SPECIAL PULL-OUT SECTION

WWW.HBANET.ORG

How to Create a Consensus on Family Land Useand Distribution

Whatever your current career position, you aspire to greater responsibility. Whatever your current skills,you must sharpen and expand them to achieve your next targeted level of accomplishment.

SKILLS FOR SUCCESSA CAREER-DEVELOPMENT COLUMN ON BUSINESS SKILLSA CAREER-DEVELOPMENT COLUMN ON BUSINESS SKILLSA CAREER-DEVELOPMENT COLUMN ON BUSINESS SKILLSA CAREER-DEVELOPMENT COLUMN ON BUSINESS SKILLSA CAREER-DEVELOPMENT COLUMN ON BUSINESS SKILLS

Olivia Boyce-AbelFounder, Boyce-Abel Associates

ell-honed financial skills are vi-tal components of any woman’ssuccess both professionally and

personally; ironically, it is the latter categorythat is often most difficult to manage. In-deed, perhaps nothing is so fraught withemotional and fiscal land mines as the dis-tribution of family land. In this “Skills forSuccess” column, Olivia Boyce-Abel, anationally recognized family lands consult-ant and mediator, imparts valuable infor-mation on how to create a family consensuson land use and distribution.

When large and valuable parcels ofland pass from one generation to the next,they often carry with them unresolvedproblems. Some heirs may wish to pre-serve the land in the family, while othersmay wish to dedicate the land for con-servation. Still others may wish to developall or some portion of the property, andothers may wish to change its productiveuse. Often the land represents a substan-tial percentage of the inherited wealth,and some of it may need to be sold topay debts, provide liquidity, or pay taxes.To resolve their conflicts over land issues,family members need to arrive at a con-sensus. Below are four basic steps, andthe skills necessary to facilitate consen-sus-building.

Step 1. Get Started Today!It is never too early to begin thinking

about what you want to do with yourfamily land. The first and most impor-tant step in this process is to get started;the longer you delay, the more opportu-

nities arise for misunderstandings andfuture mismanagement of your land.Block out some quiet time, put pen topaper, and honestly assess what you wantto do with the land. Ask yourself: “Whatdoes this land mean to me? Who do Iwant to pass it on to and what do I wantdone with it?” Consider your needs forand from the land while you are living.(Retirement? A second source of income?)Then consider your surviving family’swants or needs for the land and how thoserequirements might mesh or conflict withyour goals.

Step 2. The Family MeetingOnce you have a clear understanding

of what your land means to you and whatyou would like to see happen to it—forpresent and future generations—it is timeto reach out to your family about the land.In order for a consensus to occur, familymembers need to be willing to meet inorder to resolve whatever their land is-sues are.

● Broach the Issue and EstablishInterest Levels With younger childrenwho have not yet reached autonomy, becareful how you broach the topic. Tryusing non-threatening “what if” state-ments such as: “If I were to die, this iswhat I would want done with the land.”Let your sentiments be known and gaugetheir responses. With older children whoare financially independent of you, or forspouses, siblings, or other non-dependentfamily members, it is possible to be morestraightforward: “I am devising a plan forwhat I would like done with my prop-erty after I die. This is what I am think-ing. What are your thoughts about this?”Any level of this process would be aided

by the presence of a facilitator.● Schedule the Meetings/Set Your

Expectations The process of reaching aconsensus usually requires a series of fam-ily meetings over a period of time. Thelength of time will vary according to thecomplexities of issues in dispute, the per-sonal dynamics among family members,and the rapidity with which an agreementcan be reached. Intervals between meet-ings give family members an opportunityto do their homework, which includesmeeting with individual attorneys, ac-countants, spouses, and heirs, as well asallowing time for environmental studies,appraisals, surveys, etc. An effective meet-ing schedule is every two to three monthsover the course of a year. This timetableallows an appropriate break betweenmeetings while maintaining a frequencynecessary to decision-making momen-tum within the group. It is important thatyou and your family set your expectationsfrom the beginning—this is a process thattakes time, patience, and intelligent com-promise. Good consensus buildingdoesn’t happen overnight.

● Hire a Facilitator/Mediator Basedon my professional and personal experi-ence, I know that families reach morethoughtful, solid decisions about the fu-ture of their lands when their sessions areprofessionally facilitated/mediated. Whilethe roles of a facilitator and a mediatorare similar, they are not the same. A fa-cilitator organizes and focuses meetings,lays the ground rules, and makes sure thateveryone is heard in an orderly fashion.He/she treats members of the group withan evenhanded respect, listens, gives ac-tive feedback, and recognizes all partici-pants while maintaining impartiality. A

W

UCB Pharma, Inc., headquartered inAtlanta, GA, seeks an experiencedProduct Manager for our Zyrtec brand.This entrepreneur must possess excellentdiplomacy and negotiation skills as wellas 2-3 years’ Pharma sales experiencewith one year as a DM, NAM, or RegionalMarketing/Training and 1-2 years’Product Management experience.

Other important abilities are:

•Brand management •Business plan development, P&L

•Agency, review committee & association experience

•Matrix Management •DDMAC regulation knowledge•MBA or post-graduate work in

Pharmaceutical Marketing a plus.

Qualified candidate should also haveproduct launch and co-promote experience,market research background, and allergy/respiratory sales and/or marketingexperience. Requires 50-60% travel.Excellent salary and benefits!

Please fax resume to: HR, (770) 970-8482

or Email: [email protected]

Pharmaceutical Product ManagerWe’ve

Got The

PrescriptionFor A

GreatCareer!


WWW.HBANET.ORG

SKILLS FOR SUCCESS

The HBA Bulletin invites you tocontribute to this column. Tell us whatskill-building topics you would like to

see covered in the future.

mediator has all of the facilitator’s skills,but also is skilled at helping family mem-bers to: solve problems, empathize withdifferent viewpoints, arrive at conflictresolution, help everyone reach a consen-sus, achieve a fair and equitable balance,create a sense of harmony in conflict reso-lution, and preserve and actuallystrengthen family ties. Especially in highlycomplex situations where there is a widedisparity of viewpoints, a mediator is of-ten essential to achieve consensus. To lo-cate a facilitator or mediator near you,contact: Association for Conflict Resolu-tion (ACR) at 202-464-9700 or via theirwebsite at www.acresolution.org.

To learn more about the process of con-sensus building, read: Getting To Yes: Negoti-ating Agreement Without Giving In by RogerFisher and William Ury(Houghton Mifflin Co.) andGetting Together: Building Re-lationships As We Negotiate,also by Fisher and Ury (Pen-guin Press).

Step 3. Formalizing theConsensus

Any and all agreementsmust be formalized in writ-ing via legal documenta-tion. Once a consensus hasbeen reached, it’s time tomeet with a financial plan-ner (if the land is a large es-tate, an attorney specializ-ing in estate planningwould be best). These ex-perts can offer options forbest achieving your objec-tives. They also may be ableto devise creative strategiesfor land use and distribu-tion. For a list of some ex-cellent resources for learn-ing more about these op-tions, please see the box inthis section.

● Gifting Begin gifting portions ofthe land during your lifetime. It is oftena wise financial decision and it is a way tomentor. Gifting parcels of land to familymembers helps to invest them in the wel-fare of the land and teaches them how to

care for and value property. (Gift care-fully and make sure family member re-cipients are able to afford the additionaltaxes and money for upkeep if applicable.Your financial advisor will help you de-vise a plan for gifting appropriately.) Gift-ing land to conservation groups or chari-table organizations is also a wonderful wayto “pass on” what you have gainedthrough land ownership — plus, giftingin this manner provides an important taxsavings during a time in your life whenyou are seeking to pare down, rather thanadd to, your expenses.

● Conservation Easements An essen-tial way to protect land use when gifting isto include a conservation easement. This le-gal agreement enables a landowner to vol-untarily restrict the type and amount of de-

velopment that may takeplace on his/her property.Each easement’s restrictionsare tailored to the particularproperty, the interest of theowner, and the resources be-ing protected.

● Family Limited Part-nerships and Trusts Thesetwo vehicles help familiesbuild lasting and intelligentland use agreements by treat-ing the land almost as if itwere a family-owned com-pany divided into stock-holder shares with money in-vested for its continued pros-perity.

● Clauses for FutureGenerations It is impera-tive to keep future genera-tions in mind when craft-ing your current land dis-tribution agreement. (If theconsensus you are buildingnow applies to your chil-dren, it is important to con-sider its impact on their

children and their children’s children). Agood financial planner or estate attorneywill help you address these issues by struc-turing your agreement to include aspectssuch as endowment funds (monies in-vested and earmarked exclusively for on-going property maintenance and repair)

and “buy out” clauses. A “buy out” clausegives each family member the option tobuy out another should one family mem-ber seek to sell his/her portion of the land.This arrangement alleviates excessive fi-nancial burden and also increases the like-lihood that the property will remain in-tact and in the family.

Step 4. Keep It CurrentYour plans should be evaluated every

three to five years since relevant tax andestate laws often change. In addition,evolving family situations may impact thestructure of your land distribution plan,making regular assessments of this planimperative. Keep in mind that estate taxesand federal income taxes fall under fed-eral control and are “universal,” but cer-tain tax laws and other relevant legisla-tion that might apply to your particularsituation are decided at the state level. Forthis reason, it is important that you andyour financial advisor are aware of themost current federal and state laws.

As with most things in life, the mostimportant components of successful (andpeaceful) family land distribution are clearcommunication and planning. �

Olivia Boyce-Abel of Boyce-Abel Associatesfounded Family Lands Consulting (FLC)in 1994 to assist families in preserving theirland as well as their family accord. A na-tionally-known facilitator/mediator, shecounsels individuals and families on issuesof transference and preservation of familyhomes and lands. Her work includes facili-tating family decisions, mediating their dis-putes, and assisting in implementation offamily plans. For additional information,you may contact Ms. Boyce-Abel at FamilyLands Consulting, 1003 Smith Grade,Santa Cruz, CA 95060; Phone: (831)469-9223, Fax: (831)421-9223, Email:[email protected].

RESOURCES FORLEARNING ABOUT

YOUR OPTIONS● Conservation Options:

A Landowner’s Guide(a publication of theLand Trust Alliance)

● Preserving FamilyLands: Books I, II, andIII, all by StephenSmall (LandownerPlanning Center)

● Beyond Death andTaxes by GregoryEnglund (EstatePlanning Press)

● Passing It On: TheInheritance and Use ofSummer Houses byJudith Huggins Balfe(Pocomo Press)

● How to Pass It On:The Ownership andUse of SummerHouses by KenHuggins & JudithHuggins Balfe(Pocomo Press)

● www.familylands.com

● www.lta.org (the website for the Land TrustAlliance)

WELCOME NEW MEMBERS

HBA CALENDARSEPTEMBER 8th, 2003

EVENING SEMINAR

High-wire Act: Maintaining Career MomentumWhile Changing Fields

5:30 – 8:15 PM

Pfizer Inc, New York City, NY

SEPTEMBER 25th, 2003CONNECTIONS Program

5:30 – 8:15 PM

Glenpointe Marriott, Teaneck, NJSponsored by Eisai Inc.

OCTOBER 14th, 2003EVENING SEMINAR

Women and Stress—In and Out of the Workplace5:30 – 8:15 PM

St. Joseph’s University, Philadelphia, PACo-Sponsored by GlaxoSmithKline &

St. Joseph’s University

NOVEMBER 5th, 2003EVENING SEMINAR

Regulatory and Legal Compliance—Impact on Company Policy

5:30 – 8:15 PM

Bristol-Myers Squibb Company, Princeton, NJ

Meredith AbreuNutricise

Michele AdamiJoanne Afarian

MillenniumPharmaceuticals

Poonam AlaighGlaxoSmithKline

Lynn M. AllenPechiney

Joann ArmitageForest Laboratories

Melinda ArmstrongPfizer Inc

Laura BenoitWyeth

Lynn BodarkyKathleen Borie

PricewaterhouseCoopersMichele Braddock

All-Ways AdvertisingDeborah S. Briggs

Pfizer IncCarolyn Buck-Luce

Ernst & YoungKimberly Callahan

Novartis PharmaceuticalsCoporation

Donna CasparroParexel MMS

Lisa CastanedaAbbott Laboratories

Diana Chen MDAbbott Laboratories

Cathy CheneySchering Corporation

Mary ChristianJohnson & Johnson PRD

Leslie Cirillo PlanteNovartis PharmaceuticalsCorporation

Cindy ClarkMedCases, Inc.

Cara CocroftBaxter Healthcare

Milagros CollyerNelson Professional Sales

Lenka ContrerasKline & Company, Inc.

Tara CostelloDallabrida & Associates

Nicola CrawfordWarner Chilcott

Susan CurranWyeth

Katie CurranSimpson HealthcareExecutives

Alexis DavisAbbott Laboratories

Kathryn DavisWyeth

Deni DeaseyAstraZenecaPharmaceuticals LP

Toni DeMolaSchering-PloughCorporation

Yvonne DitoroWyeth

Gail D. DugasFinancial NetworkInvestment Corp

Tricia ElkintonAbbott Laboratories

Laurie ErmentroutOCC, North America

Louvel FauntroyPfizer PharmaceuticalGroup

Nancy FeatherstoneAstraZenecaPharmaeuticals LP

Diane FennimoreAmerican Cancer Society

Joyce B. FinkelsteinCMR Institute

Maria FlamishJane Forbes

Consult ForbesNancy Forni

Ipsos Insight HealthRuthann Fowler

Genentech, Inc.Sonya Funkhouser

Ortho Biotech Products, L.P.Cynthia Gage

Medco HealthNaima L. Gibson

VoxMedica CompanySandra Glucksmann

MillenniumPharmaceuticals

Karen GoldboroughCovance

Lissa GoldensteinArgonaut Technologies

Joy GrayPACE, Inc., a LoweHealthcare Company

Ellen GudewillThe Medicine Company

Denice Gustin-PiazzaWealth Planners

Doreen C. HackeyWyeth

Carol HardingETHICON, Inc.

Eileen Henry-LewisMedical WorldCommunications

George HradeckyMedical Economics

Ginny HsiehRoche Laboratories, Inc.

Erin E. HufmanNovartis PharmaceuticalsCorporation

Tracy A. HurdAbbott Laboratories

Tammy Jackson-WarnerSchering-PloughCorporation

Shailendra JainBusinessEdge Solutions

M. Kathryn Jones MA, MScAstraZenecaPharmaceuticals LP

Kelly KalmesProject Knowledge, LLC

Wanda Roden KearneyAbbott Laboratories

Jennifer KelleherAdvanced…the marketdevelopment company

Reshema KempsNovartis PharmaceuticalsCorporation

Cathy L. KerznerCardinal Health - MedicalEducation Services

Bernadette KingGlaxoSmithKline

Maureen KushmoreOrtho Biotech Products, L.P.

Mai LakeChristine Landy

Novartis PharmaceuticalsCorporation

Mary LaudiseSchering-PloughCorporation

Jill LazarJennifer LeBlanc

Nektar Therapeutics

Lisa LengelEisai Inc.

Monica LinOrtho Biotech Products, L.P.

Randy Lumia PHRMyrlene Macera

AstraZenecaPharmaceuticals LP

Debra MartinInComm Solutions

Suzanne MattesonMatteson ConsultingGroup

Elizabeth McCabeHunt Howe Partners

Julie McDanielGenactis, Inc.

Ruth McGeeCMRI

Tracey McGowanAcurian, Inc.

Kevin McGuireImperative Resources

Deanne MelloyOrtho Biotech Products L.P.

Kathryn MileaTorre LazurCommunications

James MillerHCPro, Inc.

Diane MlynarskiWyeth

Joseph MogaveroPfizer Inc

Natalie NassPurdue Pharma, L.P.

Michael O’BrienEisai Inc.

Jill OroszNovartis Pharmaceuticals

Dana OsolinikInnovex

Maribeth PawlakParexel MMS

Lori Ann Puleo-JurczakPACE, Inc., a LoweHealthcare Company

Nancy ReidFred Blurton Productions

Randi RobertsPfizer Inc

Diana RogersMedPharmCommunications

Dawn SaittaSBI and Company

Mindell SeidlinEisai Medical Research Inc.

Shelle M. SepePfizer Inc

Sonali ShahPfizer Inc

Bari SheinClear ChannelCommunications

Angela SidotiInnovex

Beth SilversteinSciLucent, LLC

Ann SimonsWyeth

Christine SimpsonLanmark Group

Emily SkorNichols-Dezenhall

Jessica Thompson SomolMillenniumPharmaceuticals

Caren SpeizerDaughters of Mirian Cen-ter/ The Gallen Institute

Karen M. SpoffordPowerful Execution

Christine StegmanAbbott Laboratories

Carolyn SteinbergRobbyn Stephen

Johnston, Zabor,McManus Inc.

Jo-ann StraatSankyo Pharma Inc.

Denise StraussBayer Corporation

Sonya Suarez-HammondGlobalWorks

Maureen SvobodaBristol Myers SquibbCompany

Susan SweeneyBristol Myers SquibbCompany

Vicky SwiftSwift Media Group

Mary T. SzelaAbbott Laboratories

Joanne TaylorMedco Health Solutions, Inc.

Melinda S. TaylorCorporate HOPE

Sheri ThornbergCardinal Health - MedicalEducation Services

Lisa Fosco ThrunVicki ToranCarol Turney

Novartis PharmaceuticalsCorporation

Maryon Van Tassel-ClarkVan Tassel-ClarkAssociates

Katie VecchianoMcMahon Publishing

Angelica VegaHoffmann-La Roche Inc.

Michele VitelliSaint Joseph’s University

Niti WaliaPfizer Inc

Katherine WaltmanNovartis PharmaceuticalsCorporation

Jennifer WarfCBC/American HerpesFoundation

Donna WeberHealthSTARCommunications

Janice WheelerEisai Medical Research Inc.

Carol Lewis WileyAdvantage Healthcare Inc.

Barbara WingetPfizer Inc

Jacqueline WoiciechowskiStat-Care Pharmacy

Christine WrenVMS, Inc.

Linda WrightInComm Solutions

Yue YuPfizer Inc

David ZaritskyPromex Medical Inc.

Mary Lynn ZimmermanColumbia MedComGroup

Denise ZoncaAstraZenecaPharmaceuticals LP

HBA Launches its “Pathways” GroupIf you’re new to the healthcare industry, now is your chance to join

a group specifically designed to help you advance your career.The HBA has formed Pathways, a new subgroup for those who have

been in the healthcare and related industries overall or withintheir functional area five years or less. Pathways’ goal is to lead you

into higher management and executive levels in the field.

Join us for the Pathways inaugural event:

Pharma 101: Understanding Key ProcessesDate: Fall 2003

Sponsor/Location: BusinessEdge Solutions, East Brunswick, NJ

Watch your mail and visit www.hbanet.org for more details.


WWW.HBANET.ORG


Margaret GardnerManaging Director, Global MedicalCommunications LLC

hat is advocacy? Is it productendorsement? Does legisla-tive lobbying by patient

groups constitute advocacy? What aboutthe support of key physicians—is thatadvocacy? The industry executives gath-ered at Ortho Biotech Products, L.P.(Bridgewater, NJ) for the May 28th HBAExecutive Women’s Breakfast each had adifferent opinion of advocacy and the roleadvocates play in an overall brand develop-ment strategy. During the two-hour pro-gram, these opinions were discussed andkey tactics for developing effective advo-cacy relationships were identified.

Shellie Caplan, President Caplan As-sociates Inc.(East Hampton, NY) andChairwoman of the Executive Women’sBreakfast Program series, introduced themorning’s speakers, including MaryMcGovern, Senior Director, Patient Ad-vocacy, Ortho Biotech Products L.P.,Robin L. Winter-Sperry, MD, President,Scientific Advantage LLC (Far Hills, NJ),and Christopher J. Neumann, PharmD,Executive Vice President Scientific Affairs,Enhanced Marketing, Ltd. (Woodbridge,NJ).

Following Caplan’s introduction, thespeakers presented their views of advo-cacy and advocacy relationships.

McGovern, who started a patient advo-cacy department for Ortho Biotech in1993, noted that “advocacy is not prod-uct endorsement, biased, narrowly fo-cused, exclusive, or a short-term fix. Ad-vocacy is the development of key, long-term relationships and initiatives, de-signed to help the patient.” She freelyadmits that relationships with patientadvocacy groups also benefit the com-pany, since important information aboutcompany products is often disseminatedthrough the groups to the patients. How-ever, the relationship between the com-pany and the advocacy group always hasto be win-win, and both have to be “in itfor the long-run.” “We are not aboutfunding and walking away,” McGovernemphasized. “For the relationship to workthere must be a mutual interest in work-ing together to reach patients and im-prove their care.”

Focus on Opinion LeadersWinter-Sperry and Neumann both

focused their presentations on “key phy-sician opinion leaders.” Neuman high-lighted the need to be very careful aboutrelationships built between physiciansand manufacturers and/or their agenciesin the current regulatory environmentthat is relatively conservative. Two impor-tant issues to him are:“Why do thoughtleaders think the way they do?” and“Where does all the knowledge capital

about a thought leader go when an indi-vidual working closely with a physicianleaves a company?” To answer these ques-tions, Neumann presented an overviewof his proprietary thought leader database.He noted that although most companiesrecognize the value of physician thoughtleaders when it comes to building theirmarkets and brands, few companies in-vest in a systematic way to identify, de-velop, and manage these important indi-viduals. Winter-Sperry agreed that keyopinion leaders can have a significantimpact on a company’s business. Sheunderscored the need to have a mainpoint of contact for the physician, so thatresearch, medical, sales, marketing, andinternational staff don’t all contact theperson with competing requests. Her rec-ommendations for using key opinionleaders strategically are to “be clear on whyyou want to work with a particular opin-ion leader on a particular project. Iden-tify the individual’s strengths, and under-stand the best function of the relation-ship. Work with these thought leadersstrategically to enhance your company’simage of scientific leadership, learn aboutgaps in the target product profile, andhelp transition from research to “real-world” conditions that may impact busi-ness objectives.”

What’s the bottom line? Advocacy rela-tionships are relationships, like any other. Thesame principles apply: honesty about whateach party brings to the relationship, com-mon goals about what must come from therelationship, and knowledge of each party’sstrengths and weaknesses. �

HBA EXECUTIVE WOMEN’S BREAKFAST

Advocacy Relationships: Friend or Foe?

W


ing the healthcare industry — has erodedover the last few years. Importantly, be-cause trust is the foundation of oureconomy, it is essential to reestablish ahigher level of trust in our society.

“To enhance trust in ourselves ashealthcare leaders, we need to put pa-tients’ needs first and make sure all ouractions reflect the highest degree of in-tegrity. In addition, the industry must doa better job of communicating to the general public about whowe are, what we stand for, and the value we deliver,” McGlynnnoted. “We can’t let the bad examples in the press define ourpublic image,” she continued.

McGlynn went on to say that it is ourresponsibility to improve access tohealthcare by supporting the moderniza-tion of Medicare by adding a prescrip-tion drug benefit to the program, therebyaddressing the problem of 40 millionuninsured Americans and helping to ridthe healthcare system of inefficiencies andover-utilization of benefits. She noted thatin the interim, the industry must con-tinue to fill the gap with philanthropic

programs that benefit patients whose other alternatives are lim-ited.

McGlynn also shared her philosophy for balancing the re-turn to LEADERSHIP CONFERENCE on page 6

“It’s all about ethics and integrity.This is what separates mediocre from

great. Were you willing to say: ‘Imade a mistake?’ This is a very

important characteristic of a leader.”—MARGARET G. MCGLYNN


sponsibilities of different leadership roles. Citing a principle ofSteven Covey, she encouraged the audience to “define the im-portant roles you play in life and establish goals and prioritiesin each one.” “Then,” she added, “you must have the disci-pline and courage to stick to those principles.”

Industry Executives LeadInteractive Workshops

Five interactive workshops provided participants with theopportunity to learn new leadership skills, concrete tools andtips to apply in their own environment. Workshop panelistsand moderators were all senior-level women in the healthcareindustry who addressed one of the five arenas of personal lead-ership: Company, Community, Colleagues, Family, and Self.Following are some highlights from each of the workshops.

● CompanyModerated by Shellie Caplan, President, Caplan Associates (East

Hampton, NY), this workshop focused on the premise that theskills needed to lead effectively differ depending on the businesscontext. According to speaker Paul Ofman, PhD, Senior Consult-

ant, RHR International Company (New York, NY), leadershiprequirements should be determined by the specific type of business,job function, and stage in the business cycle. For example, a leaderin a company in a rapid growth phase might require different at-tributes from one in a company in the midst of a merger integra-

tion process. Other speakers in this workshop were KathleenMilligan, VP, Marketing and Sales, Endeavor Pharmaceuticals,Inc.(Parsippany, NJ), Wendy Nielsen, RN, President, Health Learn-ing Systems (Wayne, NJ), and Robert Posch, Director, Team Leader,Global Learning and Development, Pfizer Inc. (New York, NY).

● CommunityModerator Sarah S. Harrison, VP, Customer Strategy Integra-

tion, AstraZeneca Pharmaceuticals LP (Wilmington, DE), broughttogether a distinguished panel of experts for this workshop, includ-ing Lucille C. Norville Perez, MD, President of the National Medi-cal Association (Bethesda, MD); Gina Bolden-Rivera, Senior VP,CCO, Community Capital Bank (New York, NY); MicheleDahan, Operations Manager, Relationship Marketing, Pfizer Glo-bal Pharma (New York, NY); and Luanne Byers, VP, Corporateand Community Affairs, AstraZeneca. The workshop illustratedthe old adage, “From those who are given much, much is expected,”and emphasized the need for women in leadership roles to givesomething back to the community. Harrison and Perez presenteddata on the disparity in quality of healthcare among minority popu-lations in the United States. They called on healthcare leaders toaddress this disparity through advertising, education and researchtargeted to and inclusive of minority populations.

● ColleaguesHistorically, colleagues have not collaborated but competed

for people, resources and power. However, according to Mod-erator Mary Gadek, Senior Director, New Product Market-ing, Aventis Pasteur Inc. (Swiftwater, PA), and HopeGreenfield, CLO, Lehman Brothers (New York City, NY),the organization of the future will require partnering, not com-petition. The keys to successful partnering and collaborationare: a belief in your partners’ capabilities; a trust your partnerswill follow through; and a system of accountability for any short-falls that occur. “Most people don’t partner naturally, becausethey feel there isn’t enough time and it’s easier to do it them-selves. Yes, solos are easier than partnerships, but collaborationprovides people, capital and ideas beyond what you alreadyhave,” Greenfield emphasized. Lisa Courtade, most recentlyDirector of Global Business Research, Pharmacia Corporation(Peapack, NJ), presented a checklist of ideas for working withcolleagues effectively, and suggested making it a habit to net-work with as broad a group of people as possible to keep ideas


TIME TO MAKE A DIFFERENCE

The HBA is a volunteer group, and itssuccess is due to countless hours oftime spent by members to plan andexecute programs, publications, andother services.

At the June Leadership Confer-ence, HBA President NancyLarsen, President, PROmedicaCommunications, Inc. (New York,NY), honored SHELLIE CAPLAN,President, Caplan Associates, Inc.

(East Hampton, NY) as the recipient of the HBA’s “Time to Make a Difference”award. Caplan has been active in the HBA for nearly two decades—helping toshape the Association through her role on the Board of Directors and in keyleadership positions on various HBA committees. Currently, she chairs theHBA’s enormously successful Executive Women’s Breakfast series which shehelped develop and launch.

Company Workshop Panel (left to right): PAUL OFMAN, PhD,RHR International Company; SHELLIE CAPLAN, Caplan Associates, Inc.;

ROBERT POSCH, Pfizer Inc; WENDY NIELSEN, RN,Health Learning Systems, a CommonHealth Company; and

KATHLEEN MILLIGAN, Endeavor Pharmaceuticals, Inc.

The Community Workshop Panel included (left to right)SARAH S. HARRISON, AstraZeneca Pharmaceuticals LP;

LUCILLE C. NORVILLE PEREZ, MD, The Cave Institute; andGINA LAUREN BOLDEN-RIVERA, Community Capital Bank.

fresh. An interac-tive case studyhelped the groupput the concepts ofcollaboration intopractice.

● Family“I once saw a

Ziggy cartoon thatread: ‘How comethere’s so muchmonth left at theend of my check?’ That’s how I feel about my time: How comethere’s so much ‘to do’ left at the end of my day?” said JulieKampf, workshop moderator and President of the executivesearch firm JBK Associates, Inc. (Englewood, NJ). Kampf isnot alone in this feeling. A survey conducted before the work-shop indicated that balancing work and family is a universalchallenge: 95% of those who responded said that they werenot effectively managing all they need do, and 100% said theywould like to have alternative work arrangements, such astelecommuting, unpaid time off, or more vacation time as toolsto help manage the work vs. family dichotomy. In an interac-tive discussion, workshop participants traded tips and tech-niques for handling travel, commuting, unscheduled work, ande-mail bombardment. Speakers and facilitators for this work-shop included Olga Beattie, Manager of Diversity and WorkEnvironment at Merck & Co., Inc. (West Point, PA); NatalieGahrmann, MA, Principal, N-R-G Coaching Associates

(Hillsborough, NJ); Connie Herman, President and CEO,Strategic Learning Inc.(Cottonwood, CA); Marisa Thalberg,President, Executive Moms and Senior VP of Marketing andBusiness Development, SureFit, Inc. (New York, NY); andCynthia Uber, VP, Medical Services and Quality Assurance,Eisai Inc. (Teaneck, NJ).

● SelfThis workshop, moderated by Ceci Zak, Director of Customer

Marketing, Roche Laboratories, Inc. (Nutley, NJ), incorporated aseries of interactive exercises to help participants apply their new


tion). Donna used a recombinant FSH medicine, developedand manufactured by Organon, to stimulate her ovaries toproduce eggs. The eggs were mixed with Joseph’s sperm andsome of the fertilized eggs were placed in Donna’s uterus. Apositive pregnancy test and the birth of a baby girl madethe four years of her battle with infertility worth all the physi-cal and psychological stress as well as the cost.

If you have a story about the GOOD our industry does,please share the pride and email it to me at [email protected] please feel free to pass along these examples of why we allhave pride in what we do. �

PRESIDENT’S FORUM from page 8

leadership skills athome. DeborahBright, a formerOlympic high diverand President ofBright Enterprises,Inc. (New York,NY), taught thegroup the “QuickCharge” techniquesshe used in compe-tition to help main-tain perspective andfocus under stress. Akey component of “Quick Charge” is switching your focus frommicro to macro to maintain perspective by taking a broader viewand identifying the impact of the details on achieving the greatergoal. Delia Passi Smalter, President of Medelia Communications(Irvington, NY), noted that to reach a personal best, one must strikea balance between too little and too much stress. “An individualthat over-functions in one of her life roles usually ends up under-functioning in another, or encouraging others to under-function.Do too much, and others will do too little. The result is a depletionof your resources and a strain on your relationships,” says Smalter.

A Word of ThanksThe Leadership Conference planning team contributed count-

less hours to pulling the meeting together and should be commendedfor a fine job. “It takes many people to make sure a conference asimportant as the HBA’s Women’s Leadership Conference addressesthe myriad issues its members face. . . by securing the right speakerswho will address the right topics and providing the right skill-build-ing experience. Our thanks to the 17 other volunteers (see page 8)who worked together to produce this exceptional and record-break-ing conference,” said Donna Ramer, President, HealthMed Com-munications (New York, NY) who co-chaired the conference withAnne Camille Maher, Principal, Health Leaders Consultancy(Hopkinton, MA). Conference attendees were equally positive.“Attending the HBA Leadership Conference exceeded my expecta-tions,” said Karen Spofford, Executive Coach. “The opportunityto connect with talented professional women in the healthcare in-dustry is what the HBA is all about.” �

The Colleagues Workshop Panel (left to right):LISA COURTADE; HOPE GREENFIELD,

Lehman Brothers; and MARY GADEK,Aventis Pasteur Inc.

The Family Workshop Panel (left to right): MARISA F. THALBERG,Sure Fit, Inc.; CONNIE JEANNE HERMAN, Strategic Learning Inc.;

JULIE KAMPF, JBK Associates, Inc.; NATALIE GAHRMANN,N-R-G Coaching Associates; OLGA P. BEATTIE, Merck & Co.; and

CYNTHIA L. UBER, Eisai Inc.

The Self Workshop Panel (left to right):CECI ZAK, Roche Laboratories;

DEBORAH BRIGHT, PHD, Bright Enterprises;and DELIA PASSI SMALTER,Medelia Communications.

HBA CORPORATE MEMBERSHIPAbbott Laboratories LLC

Accel LLCAccelera

American Academy of Family PhysiciansAmerican Medical Association

AstraZeneca ChicagoAstraZeneca Pharmaceuticals LP

Bradin Search Group, Inc.Bristol-Myers Squibb Company

BusinessEdge SolutionsCap Gemini Ernst & Young

Cardinal HealthChandler Chicco AgencyCline Davis & Mann, Inc.Clinical CONNEXION

Communications Media Inc.Compas, Inc.

CovanceDimensional HealthCare, Inc.

Dorland Global Health CommunicationsDowden Health Media

Eisai Inc.Elsevier Inc.

Ernst & YoungETHICON, Inc.

FCB HealthCareFleet Bank

Genentech, Inc.Gibbons, Del Deo, Dolan, Griffinger & Vecchione, PC

GlaxoSmithKlineGrey Healthcare Group Inc.

Guidant CorporationHealth Resource Publishing

Herlitz HealthCare: A Communications CompanyHill & Knowlton, Inc.

Hoffmann-La Roche Inc.IBM Consulting Services (PWC)

inChord CommunicationsInnovative Media Research

Innovative Medical EducationInternational Medical News GroupInternational Meetings & Science

Janssen PharmaceuticaJohnson & Johnson PGSM

KPRLally McFarland & Pantello Inc.

Lyons Lavey Nickel Swift, Inc.The Mattson Jack Group

M/C CommunicationsMediVia

Medivisor, Inc.Medsn Inc

Merck & Co., Inc.Merkley Newman Harty Healthworks

NCI Advertising, Inc.NewtonGravityShift

Novartis Pharmaceuticals CorporationOCC, North America, Inc.

Organon Pharmaceuticals USA Inc.Ortho Biotech Products, LP

Ortho-McNeil PharmaceuticalOxford Institute for Continuing EducationPACE, Inc., a Lowe Healthcare Company

Palio CommunicationsPfizer Inc.

PROmedica Communications, Inc.Regan Campbell Ward

Reliant Pharmaceuticals, LLCSaatchi & Saatchi Healthcare Group

Sanofi-Synthelabo, Inc.Schering-Plough Corporation

SCP Communications, Inc.SimStar Internet Solutions

SoftWatch Inc.Solvay Pharmaceuticals, Inc.

Stratagem Healthcare CommunicationsSudler & Hennessey/IntraMed

Thomson Healthcare Inc.Unlimited Performance Training

VOX Medica, Inc.Wyeth

HBA ADVISORY BOARDJulia Amadio, Aventis, Inc.

Sharon Callahan, SummitGREYCarrie S. Cox, Schering-Plough Corporation

Nadine Craig, UCB Pharma Inc.Maria DeGois-Sainz, Guidant Corporation

Lisa Egbuonu-Davis, Pfizer Inc.David Epstein, Novartis Oncology

Debra Freire, Novartis Pharmaceuticals CorporationMatthew Giegerich, CommonHealth

Kathleen Harrison, Pharmaceutical Media Inc.Sarah Harrison, AstraZeneca Pharmaceuticals LPMichael Hickey, AstraZeneca Pharmaceuticals LP

Joanna Horobin, MD, CombinatoRx Inc.Tamar Howson, Bristol-Myers Squibb Company

Heidi Hunter, WyethKaren Katen, USPG, Pfizer Inc.Louis J. Manzi, GlaxoSmithKline

Charlotte McKines, Merck & Co., Inc.Paula Meade, Hoffmann-La Roche Inc.

Louise Mehrotra, Janssen Pharmaceutica, L.P.Myrtle Potter, Genentech, Inc.

Sylvia Reitman, International Medical News GroupTimothy Rothwell, Sanofi-Synthelabo

William C. Sheldon, Eisai Inc.Charlotte E. Sibley, Millennium Pharmaceuticals, Inc.

Catherine A. Sohn, PharmD, GlaxoSmithKlineRita Sweeney, Dorland Global Health Communications

Lynn O’Connor Vos, Grey Healthcare Group, Inc.Carol Webb, Ortho Biotech Products, LP

Sheila Wellington, Catalyst

PRESIDENT’S FORUM

June 6th: Not Just Another Day at theJersey Shore and Another Reason WeShould be Proud to be in HealthcareNancy LarsenHBA President


The 250 women whoattended the HBA’sWomen’s LeadershipConference on thebeach in Long Branchare still basking in theafterglow of our bestConference to date.From the spa treatmentsto the pre-conferencedinner the night beforethrough the full day of

general sessions and highly targeted work-shops, all of us networked, learned, dis-cussed, networked again and then learnedand discussed some more. In fact, many ofus are still discussing the topics and issues

brought to light about the many Responsi-bilities of Leadership.

Personally, I haven’t spent a more fulfillingday in a very long time. I know my colleagueswho attended felt the same way, because I’vereceived a plethora of emails and phone callsfrom them thanking the HBA for sponsoringthis event. So my thanks again to the 19 VOL-UNTEERS cited below who made this eventsuch a success.

If you were there, I know you were as movedas I was by Margie McGlynn, President, USHuman Health Care, Merck & Co., Inc, whodelivered a very impassioned—and simply awe-some—keynote address. For those of you whowere unable to attend, I really need to share afew of the comments she made, which wereon track with my theme as this year’s Presidentof the HBA as well as the theme of our“Woman of the Year,” Catherine Angell Sohn,PharmD, VP, Worldwide Business Develop-ment and Member of the Executive Commit-tee at GlaxoSmithKline (GSK) ConsumerHealthcare.

The Common Theme: Pride in OurIndustry

During her speech, Margie called on all at-tendees to help restore trust in the biopharma-ceutical industry. As we all know—and as Margieso compellingly pointed out—the healthcare in-dustry is being defined by a few bad examplesthat clearly demonstrate how not to conductbusiness. She called for all of us to help restoretrust in our industry by having three priorities inour daily jobs: (1) Put the patient first; (2) Do ourjobs with integrity; and (3) Communicate thevalue of our products.

To heed Margie’s third recommendationand to continue my commitment to share real-life examples of pride in our industry, the fol-lowing was told to me by an HBA member.

For four years, Donna and Joseph visitedfertility specialists. After Donna had surger-ies that left her without fallopian tubes, thecouple decided to try IVF (in vitro fertiliza-

Special Thanks to theHBA Leadership Conference Committee

Anne Camille Maher, Conference Co-chair, HBA Co-directorof Career Development; Principal, Health Leaders Consultancy(Hopkinton, MA)

Donna K. Ramer, Conference Co-chair, HBA Co-director ofCommunications; President, HealthMed Communications(New York, NY)

***Gerilyn Berliner, Director, Event Services, MediVia (New York,

NY)Daria Blackwell, HBA President-elect; President, White

Seahorse, Inc. (Mahwah, NJ)Shellie Caplan, Chair, HBA’s Executive Women’s Breakfast Se-

ries; President, Caplan Associates, Inc. (East Hampton, NY)Lisa Courtade, HBA Co-director of Career DevelopmentMary Gadek, Senior Director, New Product Marketing, Aventis

Pasteur, Inc. (Swiftwater, PA)Julie Kampf, Founder and President, JBK Associates, Inc.

(Englewood, NJ)Sarah S. Harrison, 2002 HBA “Woman of the Year” and Advi-

sory Board member; Vice President, Customer Strategy Inte-gration, AstraZeneca Pharmaceuticals, LP (Wilmington, DE)

Darlene Mumm, President, MediVia (New York, NY)Debra L. Newton, HBA Co-director of Marketing; President and

Co-founder, Newton Gravity Shift (Pennington, NJ)Katherin Nukk-Freeman, Director/Partner, Gibbons, Del Deo,

Dolan, Griffinger & Vecchione, PC (Newark, NJ)Margaret Paradise, Senior Client Services Consultant, Right

Management Consulting (Parsippany, NJ)Sylvia H. Reitman, Vice President, Medical Education and Busi-

ness Development, International Medical News Group(Morristown, NJ)

Arlene Rosenberg, Principal, The Rosenberg Group, Inc. (NewYork, NY)

Lisa S. Shapiro, Principal, Strategic Solutions Group (New York,NY)

Nicole Woodland, 2003 HBA “Rising Star”; Marketing Manager,Compas, Inc. (Cherry Hill, NJ)

Susan Youdovin, HBA Co-director of Communication and 1999“Star Volunteer”; President, B&Y Communications LLC(Montclair, NJ)

Christine C. Zak, Director, Customer Marketing, Roche Labora-tories, Inc. (Nutley, NJ)

turn to PRESIDENT’S FORUM on page 7

The HBA Gathers Top Industry Leaders for Groundbreaking ... · Chris McMorrow Senior Copywriter...

Documents

Transcript of The HBA Gathers Top Industry Leaders for Groundbreaking ... · Chris McMorrow Senior Copywriter...